CTNM Covered Call Strategy
CTNM (Contineum Therapeutics, Inc. Class A Common Stock), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and progressive multiple sclerosis (MS). The company also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor to treat depression and relapse remitting MS; and CTX-343, a peripherally-restricted LPA1R antagonist. Contineum Therapeutics, Inc. was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. The company was incorporated in 2009 and is headquartered in San Diego, California.
CTNM (Contineum Therapeutics, Inc. Class A Common Stock) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $529.0M, a beta of 0.89 versus the broader market, a 52-week range of 3.35-16.33, average daily share volume of 283K, a public-listing history dating back to 2024, approximately 41 full-time employees. These structural characteristics shape how CTNM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.89 places CTNM roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on CTNM?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current CTNM snapshot
As of May 15, 2026, spot at $13.72, ATM IV 140.20%, IV rank 23.86%, expected move 40.19%. The covered call on CTNM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this covered call structure on CTNM specifically: CTNM IV at 140.20% is on the cheap side of its 1-year range, which means a premium-selling CTNM covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 40.19% (roughly $5.51 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CTNM expiries trade a higher absolute premium for lower per-day decay. Position sizing on CTNM should anchor to the underlying notional of $13.72 per share and to the trader's directional view on CTNM stock.
CTNM covered call setup
The CTNM covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CTNM near $13.72, the first option leg uses a $14.41 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CTNM chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CTNM shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $13.72 | long |
| Sell 1 | Call | $14.41 | N/A |
CTNM covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
CTNM covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on CTNM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on CTNM
Covered calls on CTNM are an income strategy run on existing CTNM stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
CTNM thesis for this covered call
The market-implied 1-standard-deviation range for CTNM extends from approximately $8.21 on the downside to $19.23 on the upside. A CTNM covered call collects premium on an existing long CTNM position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether CTNM will breach that level within the expiration window. Current CTNM IV rank near 23.86% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CTNM at 140.20%. As a Healthcare name, CTNM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CTNM-specific events.
CTNM covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CTNM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CTNM alongside the broader basket even when CTNM-specific fundamentals are unchanged. Short-premium structures like a covered call on CTNM carry tail risk when realized volatility exceeds the implied move; review historical CTNM earnings reactions and macro stress periods before sizing. Always rebuild the position from current CTNM chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on CTNM?
- A covered call on CTNM is the covered call strategy applied to CTNM (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With CTNM stock trading near $13.72, the strikes shown on this page are snapped to the nearest listed CTNM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CTNM covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the CTNM covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 140.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CTNM covered call?
- The breakeven for the CTNM covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CTNM market-implied 1-standard-deviation expected move is approximately 40.19%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on CTNM?
- Covered calls on CTNM are an income strategy run on existing CTNM stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current CTNM implied volatility affect this covered call?
- CTNM ATM IV is at 140.20% with IV rank near 23.86%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.